The 65th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine / The 45th Annual Meeting of the Japanese Society of Nuclear Medicine Technology

Call for Abstracts

Period of submission

Friday, 4th April 2025 – Thursday, 24th April 2025    Friday, 9th May 2025

Guideline for abstract submission

Type of Presentation

The author can choose a preferred type of presentation. Please be advised that the Program Committee will make the final decision on the type of presentations regardless of your preference. There will be no live streaming or on-demand streaming after the conference.

  • Oral Presentation
  • Poster Presentation
  • Either will be fine

A separate email will be sent to designated speakers participating in plenary lectures, special invited talks, and symposia.
It will include detailed information on how to register, along with an official invitation letter.

Qualification

It is not required for the presenter to be a member of JSNM.

We kindly ask those whose submissions are accepted to complete their registration for participation. Registration will be opened around August to September 2025.

Abstract submission

Abstract should be submitted by UMIN online registration.
Please note that submission by email or post mail is not acceptable.

Abstract format

The number of author
(Presenter & co-author)
Assigned institution Text limit
Up to 11 persons Up to 10 institutions English (in single-byte)
Title: within 90 characters
Abstract: within 900 characters
  • Abstracts should contain TEXT ONLY (no Tables, Figures, Graphs).
  • Abstract is NOT allowed to exceed the text limit.
  • Abstract should be documented starting with purpose, procedure, result, and finishing with conclusion.

Category for application

Note for registration

  1. Please take ethical consideration.
  2. To protect the privacy of patients and examinees, please pay attention to the following points.
    1. Do not describe the name, patient number, initials or code name that individuals can be identified.
    2. The year and the month are allowed to be specified as the time factor, only in the case that the individual is guaranteed NOT to be identified.
    3. If the patients are receiving diagnosis or treatment at another hospital, do not describe the name of the facility and the location.
    4. If the individuals can be identified by combined information e.g. date of operation or hospital, describe the ages as follows.
    5. Ex) 40-44 years old: early forties, 45-49 years old: late forties
  3. Please do not use the company name or phrases that can identify the specific company in the abstract title. (Equipment or software having a registered trademark etc.)
  4. Please make sure to confirm your email address and the setting to receive the email from us. You will receive an automatic reply when you complete your abstract submission and amendment. In case you do not receive any reply within a few days, please contact the congress secretariat (jsnm-jsnmt2025@congre.co.jp). We highly recommend confirming your abstract submission on online page after online uploading.
  5. The abstract number and the password published after uploading are expected to be kept carefully, as they are required when you modify your abstract / contact the congress secretariat regarding the abstract issue. Please confirm if the uploading is successful by logging-in the "Check & Modify" page with your abstract number and password.
  6. The result of abstract selection and schedule of presentation will be announced via email after mid-July.

Conflicts of interest

Disclosure of any possible conflicts of interest (COI) is required. Please refer to the link below for the details on the principle of conflicts of interest.

Abstract submission link

※After the abstract submission deadline, it will not be possible to delete or modify registrations.

Inquiry

Congress Secretariat
c/o Congrès Inc.
E-mail: jsnm-jsnmt2025@congre.co.jp